Cargando…
Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040521/ http://dx.doi.org/10.1016/j.rcreue.2021.04.002 |
| _version_ | 1783677800101707776 |
|---|---|
| author | Jáuregui, Edwin |
| author_facet | Jáuregui, Edwin |
| author_sort | Jáuregui, Edwin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8040521 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80405212021-04-13 Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic() Jáuregui, Edwin Revista Colombiana de Reumatología (English Edition) Letter to the Editor Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. 2021 2021-04-09 /pmc/articles/PMC8040521/ http://dx.doi.org/10.1016/j.rcreue.2021.04.002 Text en © 2020 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Jáuregui, Edwin Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic() |
| title | Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic() |
| title_full | Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic() |
| title_fullStr | Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic() |
| title_full_unstemmed | Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic() |
| title_short | Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic() |
| title_sort | antimalarials (chloroquine and hydroxychloroquine) in the covid-19 pandemic() |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040521/ http://dx.doi.org/10.1016/j.rcreue.2021.04.002 |
| work_keys_str_mv | AT jaureguiedwin antimalarialschloroquineandhydroxychloroquineinthecovid19pandemic |